Latest filing published 21 Dec 2020 for Surface Oncology, Inc., €11.3M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -61.9%Entry US$43.00 · Close at T+365 US$16.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Atlas Venture Fund IX, L.P.: trading record in brief
Atlas Venture Fund IX, L.P. has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Intellia Therapeutics, Inc., Surface Oncology, Inc. and Cogent Biosciences, Inc. In total, 15 filings cover trades dated from 11 May 2016 to 17 December 2020.
Both buying and selling appear: 2 purchases worth €2.1M, against 5 sales worth €38.6M. Netting one side against the other leaves €36.5M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2020, the count stands at no purchases and 2 sales.
The record was last updated on 21 December 2020 with an open-market sale (€11.3M) in Surface Oncology, Inc. The latest purchase dates back some time: it was published 3,122 days ago, on 23 April 2018. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Atlas Venture Fund IX, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,700,000 shares@ US$8.1030.9% of flowCommon StockSEC:0001104659-20-138021:0
- 1,700,000 shares@ US$18.1069.1% of flowCommon StockSEC:0001104659-20-137966:0
- 3,181,817 sharesCommon StockSEC:0001209191-18-025826:0
- 100,000 shares@ US$15.003.3% of flowCommon StockSEC:0001209191-18-025826:1Canonical exit: 22 Jul 2018 (T+90)
- 3,184,446 sharesCommon StockSEC:0000899243-18-009264:0
- 83,037 sharesCommon StockSEC:0000899243-18-009264:1
- 94,052 shares@ US$12.00100.0% of flowCommon StockSEC:0000899243-18-009264:2Canonical exit: 2 Jul 2018 (T+90)
- 30,000 shares@ US$16.766420.7% of flowCommon StockSEC:0001104659-17-044529:0
- 40,000 shares@ US$16.172226.7% of flowCommon StockSEC:0001104659-17-044529:1
- 80,000 shares@ US$16.069552.7% of flowCommon StockSEC:0001104659-17-044529:2
- 700,000 sharesCommon StockSEC:0001209191-17-018547:0
- 611,827 sharesCommon StockSEC:0001209191-16-119316:0
- 2,463,201 sharesCommon StockSEC:0001209191-16-119316:1
- 862,120 sharesCommon StockSEC:0001209191-16-119316:2
- 492,640 sharesCommon StockSEC:0001209191-16-119316:3
15 of 15 declarations
